A Molecular and Biochemical Study for Cholesteryl Ester Transfer Protein (CETP) Taq1B in Iraqi Patients with Hyperlipidemia

被引:0
|
作者
Alkhafajy, Nagham Q. K. [1 ]
Al-azawy, Adnan F. [2 ]
Yaseen, Arshed H. [3 ]
机构
[1] Tikrit Univ, Coll Sci, Dept Chem, Salah Al Deen, Iraq
[2] Tikrit Univ, Coll Sci, Dept Biol, Salah Al Deen, Iraq
[3] Samarra Univ, Coll Appl Sci, Dept Pathol Anal, Salah Al Deen, Iraq
关键词
CETP gene polymorphisms; Cholesteryl ester transfer protein; Hyperlipidemia; Lipoproteins; SERUM TRIGLYCERIDES; GENE POLYMORPHISMS; METABOLIC SYNDROME; DISEASE; RISK; MEN;
D O I
10.21123/bsj.2019.16.3(Suppl.).0747
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cholesteryl ester transfer protein gene contains some single nucleotide polymorphisms, which have been associated with serum high-density lipoprotein concentration and other lipoproteins. This study is done for determining of cholesteryl ester transfer protein polymorphism and evaluate its effect on serum lipid profile concentrations in some hyperlipidemic patients compared with healthy subjects in Salah Al-din governorate-Iraq. Blood samples were taken from (90) patients suffering from hyperlipidemia, and (70) samples that were apparently healthy controls. Serum lipid concentrations were measured by enzymatic assays. The polymorphism was genotyped using polymerase chain reaction restriction fragment length polymorphism analysis. The results showed that there was a significant decrease (P< 0.05) in the frequency B2 allele, and B1B2, B2B2 genotype, and a significant increase (P< 0.05) in the frequency B1 allele, and B1B1 genotype between patients and controls groups. There was a non-significant decrease in the levels of high density lipoproteins, total cholesterol, low density lipoproteins, and very low density lipoproteins levels, and non-significant increase in levels of triglycerides in individuals with the B1B1 genotype than in the B1B2 and B2B2 genotype. However, high density lipoproteins showed a significant decrease (P< 0.001) between individuals with the B1B1 genotype and B2B2 genotype. Also, there was a non-significant difference in the levels of high density lipoproteins, total cholesterol, low density lipoproteins, and very low density lipoproteins levels, in individuals with the B1B2 genotype when compared with that of the B2B2 genotype.
引用
收藏
页码:747 / 753
页数:7
相关论文
共 50 条
  • [21] ENDOTHELIAL LIPASE GENE POLYMORPHISM SIGNIFICANTLY MODIFIES THE EFFECT OF CHOLESTERYL ESTER TRANSFER PROTEIN GENE TAQ1B POLYMORPHISM ON PLASMA HDL-CHOLESTEROL
    Agapakis, D.
    Goulas, A.
    Savopoulos, C. H.
    Gbandi, E.
    Hatzitolios, A. I.
    ATHEROSCLEROSIS, 2014, 235 (02) : E178 - E178
  • [22] BIOCHEMICAL BASIS OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) ACTIVITY DEFICIENCY IN 2 HYPERALPHALIPOPROTEINEMIC SUBJECTS
    MATSUZAWA, Y
    YAMASHITA, S
    SPRECHER, DL
    HARMONY, JAK
    SAKAI, N
    TARUI, S
    WETTERAU, JR
    ARTERIOSCLEROSIS, 1989, 9 (05): : A691 - A691
  • [23] The gender-specific influence of Taq1B, I405V polymorphisms of the cholesteryl ester transfer protein gene on postprandial lipemia in familial hypercholesterolemia
    Kolovou, G.
    Anagnostopoulou, K.
    Kostakou, P.
    Marvaki, C.
    Giannakopoulou, K.
    Sorondila, K.
    Mihas, C.
    Mikhailidis, D. P.
    Cokkinos, D. V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 60 - 60
  • [24] The CETP Taq1B polymorphism is associated with the risk of sudden death in type 2 diabetic patients:: The DIABHYCAR study
    Porchay-Balderelli, Isabelle
    Menard, Joel
    Pean, Franck
    Chatelier, Gilles
    Lievre, Michel
    Marre, Michel
    Fumeron, Frederic
    DIABETES, 2006, 55 : A1 - A1
  • [25] Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus
    Yilmaz, H
    Agachan, B
    Karaali, ZE
    Isbir, T
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 13 (06) : 889 - 893
  • [26] The Taq1B-variant in the cholesteryl ester-transfer protein gene and the risk of metabolic syndrome
    Sandhofer, Anton
    Tatarczyk, Tobias
    Laimer, Markus
    Ritsch, Andreas
    Kaser, Susanne
    Paulweber, Bernhard
    Ebenbichler, Christoph F.
    Patsch, Josef R.
    OBESITY, 2008, 16 (04) : 919 - 922
  • [27] PHARMACOGENOMIC STUDIES OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) GENOTYPES IN SUSPECTED CAD PATIENTS
    Tantray, Javeed Ahmad
    Kumar, Y. Shiva
    Jamil, Kaiser
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (10): : 3910 - 3916
  • [28] CHARACTERIZATION OF LDL PARTICLES FROM PATIENTS WITH DEFICIENCY OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP)
    SAKAI, N
    MATSUZAWA, Y
    YAMASHITA, S
    HIRANO, K
    UEYAMA, Y
    KUBO, M
    TARUI, S
    ARTERIOSCLEROSIS, 1989, 9 (05): : A761 - A761
  • [29] INHIBITION OF PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) ACTIVITY IN PATIENTS WITH ABETALIPOPROTEINEMIA (ABL)
    PAPPU, AS
    OMALLEY, JP
    ILLINGWORTH, DR
    FASEB JOURNAL, 1991, 5 (05): : A1071 - A1071
  • [30] Plasma cholesteryl ester transfer protein (CETP) activity in patients with primary hypercholesterolemia.
    Pappu, AS
    Illingworth, DR
    FASEB JOURNAL, 1996, 10 (03): : 3178 - 3178